The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2025

Filed:

Aug. 30, 2017
Applicants:

Genexine, Inc., Seongnam-si, KR;

Handok Inc., Seoul, KR;

Inventors:

Tae Kyung Kim, Seongnam-si, KR;

Jung Won Woo, Seoul, KR;

Joan Yoon Ji Lee, Seongnam-si, KR;

Young-Joo Ahn, Seongnam-si, KR;

Ji-Eun Cha, Seongnam-si, KR;

Hyou Young Rhim, Gwacheon-si, KR;

Woo Ick Jang, Seoul, KR;

Assignees:

GENEXINE, INC., Seongnam-si, KR;

HANDOK INC., Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/27 (2006.01); A61K 9/00 (2006.01); A61P 5/06 (2006.01); C07K 14/61 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
A61K 38/27 (2013.01); A61K 9/0019 (2013.01); A61P 5/06 (2018.01); C07K 14/61 (2013.01); G01N 33/74 (2013.01); C07K 2319/30 (2013.01); G01N 2333/61 (2013.01);
Abstract

A method for treating growth hormone deficiency, including administering a human growth hormone fusion protein (GX-H9). A method includes administering a pharmaceutical composition containing an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient.


Find Patent Forward Citations

Loading…